Asia Pacific Intraosseous Infusion Devices Market

Asia Pacific Intraosseous Infusion Devices Market Size (2023 to 2028)

The size of the Intraosseous Infusion Devices Market in the Asia Pacific has been valued at USD 1.42 billion in 2023. It is projected to grow at a CAGR of 8.1% and worth USD 2.09 billion by 2028.

Emergency medical training simulators have been launched to improve the healthcare services are a significant factor propelling the market's growth. The increasing launch of new products and the focus on getting approvals from the governments are impelling the market demand. The rise in the number of road accidents leads to emergency surgeries, driving the need for the intraosseous infusion devices market in Asia-Pacific. Adoption of sedentary lifestyles will impact human health negatively, and this is fueling the market growth. The growing number of patients visiting hospitals due to an increase in occurrences of chronic disorders is boosting the market growth. The introduction of advanced technologies in the healthcare sector to promote the treatment procedures' quality is escalating market growth. EZ-IO is an advanced technologically intraosseous device that allows quick and more efficient while performing emergency surgeries.

However, the intraosseous infusion devices are difficult to insert into the soft tissues, which leads to compartment syndrome. This factor is slowly hindering the growth rate of the market. The patients who have osteoporosis are restricted to use these devices, which are also restraining the market demand.

This research report on the Asia Pacific Intraosseous Infusion Devices Market has been segmented and sub-segmented into the following categories.

By Product Type: 

• FAST1 device
• Dieckmann Modified Needle
• BIG device
• EZ-IO device
• Jamshidi Needle
• FASTx device
• NIO

By Technology: 

• Battery Powered Driver
• Manual IO Needles
• Impact Driven Devices

By End User: 

• Hospitals
• Emergency Medical Ambulatory Surgical Centres
• Services
• Cardiac Care Centres

By Route of Administration: 

• Distal Femur
• Sternum
• Distal & Proximal Tibia
• Calcaneus
• Head of Humerus

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Based on the region, the Asia Pacific is the second-largest market and is expected to grow with the highest CAGR. It captures 30% of the global market share. 

China is holding the largest shares of the market. Increasing training sessions for medical staff to perform effective treatment procedures using intraosseous infusion devices accelerates the market demand. India is expected to have rapid growth in the market. Patients and the medical professionals accepting the intraosseous infusion devices because of the enormous benefits provided at the time of emergencies are projected to flourish the market demand. In August 2019, according to the Australian Institute of Health and Welfare’s Hospitals, admissions for emergency surgery has risen between 2016-2017 and 2017-2018 by 2.9% in public hospitals and by 5.1% in private hospitals in Australia.

Top Companies dominating the Asia Pacific Intraosseous Infusion Devices Market Profiled in the Report are PerSys Medical, Aero Healthcare, Teleflex, Pyng Medical Corp., Biopsybell, Cook Medical Incorporated, Aero Healthcare, etc.